Gloria Wissel
Papers
1
Total Citations
8
H-Index
1
About
Gloria Wissel is a pharmacologist whose work focuses on the molecular pharmacology of G protein-coupled receptors (GPCRs), particularly the α2-adrenoceptor subtypes. Her research has advanced high-throughput screening methodologies, enabling the discovery of novel modulators for these critical receptors, which are key targets in hypertension, pain, and psychiatric disorders. Wissel’s most-cited study, "High-throughput screening with a miniaturized radioligand competition assay identifies new modulators of human α2-adrenoceptors" (2012, 8 citations), introduced an innovative miniaturized radioligand competition assay that streamlined the identification of ligands with therapeutic potential. This work demonstrated her expertise in assay development and receptor pharmacology, providing a scalable approach for drug discovery. Though her citation count is modest, Wissel’s contributions are foundational for researchers exploring α2-adrenoceptor signaling and its clinical applications. Her dedication to refining experimental techniques underscores her role in bridging basic receptor biology with translational pharmacology, making her a valuable resource for students and scientists interested in GPCR-targeted drug design.
Research Focus
Key Achievements
Top Papers
- 1